Urgent.News

What's breaking now, across thousands of outlets.

More in Business

Lonza Acquires Merck U.S. CDMO Facilities, Competing with Samsung Biologics

Swiss Lonza, a global contract development and manufacturing organization (CDMO) company, will acquire the United States CDMO business of German Merck.With Samsung Biologics in the process of…

  • Lonza acquires Merck's U.S. CDMO facilities for $126.3M-$769.2M
  • Expansion to nine U.S. locations and 6,000 employees
  • Wisconsin facility specializes in anticancer drug ingredients

More from Wednesday 4 November →